<DOC>
	<DOCNO>NCT01032941</DOCNO>
	<brief_summary>The investigator address hypothesis portal hypertension mediate part bacterial endotoxin translocation production inflammatory mediator ( tumor necrosis factor-α ( TNFα ) , etc. ) . The investigator hypothesize food supplementation probiotic product VSL # 3 patient Child Pugh B/C cirrhosis beneficial effect portal pressure ( measure HVPG ) reduce inflammatory mediator improve systemic splanchnic hemodynamics .</brief_summary>
	<brief_title>The Effect Probiotics ( VSL ) Portal Hypertension</brief_title>
	<detailed_description>We recently complete open-label uncontrolled trial probiotic VSL # 3 8 patient compensated cirrhosis evidence portal hypertension ( VIP study ) determine whether agent would beneficial effect portal pressure reduction ( unpublished data Tandon , P. et al. ) . The open label design inclusion compensate ( Child Pugh A ) cirrhotic patient initial study choose confirm safety tolerance VSL # 3 safety portal pressure measurement center . No change physical status occur . There non-significant reduction portal pressure 19.7 18.1 mm Hg 2 month VSL # 3 supplementation . Furthermore , significant reduction serum aldosterone level ( p=0.03 ) . IL-8 level reduce 4/6 patient analyzed date . These result suggest VSL # 3 result cytokine reduction improvement effective circulating volume even well-compensated cirrhotic patient . The comparison rest pro-inflammatory mediator stool microflora still analyze . The data initial study promising . As patient compensated cirrhotics normal intestinal permeability mild baseline perturbation hepatic function parameter ( INR , bilirubin , albumin ) neurohormonal marker ( aldosterone , renin ) , surprising reduction portal pressure identify . Consistent previous study however , local result confirm safety tolerance VSL # 3 well portal pressure measurement cirrhotic patient ( 20,24,25 ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>Age 1880 Cirrhosis ChildsPugh Class B/C Bacterial infection Grade 34 hepatic encephalopathy GI bleeding past 2 week Hepatocellular carcinoma beyond Milan criterion Transjugular intrahepatic portosystemic shunt ( TIPS ) , surgical shunt Portal vein thrombosis Antibiotics past 2 week Myocardial infarction , stroke lifethreatening arrhythmia within last 6 month Active alcohol illicit drug use Failure consent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Portal Hypertension</keyword>
	<keyword>Portal Pressure Measurement</keyword>
	<keyword>VSL3</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>End Stage Liver Disease</keyword>
	<keyword>Probiotics</keyword>
</DOC>